RECORD // Company
Scinai Immunotherapeutics Ltd.
Formerly: BiondVax Pharmaceuticals Ltd.
Built 2026-11-22T04:58:52Z from public sources · JSON · Open the company profile
ASK THE RECORDS
Ask
COMPANY
Records for this company (1 joined by official identifier)
Every record below is joined to this company by a hard identifier: its SEC registrant record or its GLEIF ownership tree. Each line says how. Built 2026-11-18 13:42:42. Beta: records that match only by name are held apart until name matching is verified.
SEC EDGAR (1)
- Scinai Immunotherapeutics Ltd. · the SEC registrant record of this company
Records under a former name (1)
The name on these records was this company's name in the past (SEC name history). An old name can also belong to an unrelated organization, so they are shown apart and are not counted above.
- BiondVax Pharmaceuticals ltd. · Ctgov
2 VALUES · 10-Q · EACH LINKS TO ITS FILING
Latest quarter
Latest report: 10-Q for the period ended 2023-03-31, filed 2023-05-15 · accession 0001213900-23-039875
Old data: this filer's newest 10-Q or 10-K in SEC company facts is for the period ended 2023-03-31. No later report has XBRL values.
| Item | Value | Period | Form | Filed | Accession | Report | |
|---|---|---|---|---|---|---|---|
| Net income (loss) | $-3,515,000 | 3 months ended 2023-03-31 | 10-Q | 2023-05-15 | 0001213900-23-039875 | 2026-11-22 04:58 UTC | Report an error |
| Cash and cash equivalents | $10,799,000 | at 2023-03-31 | 10-Q | 2023-05-15 | 0001213900-23-039875 | 2026-11-22 04:58 UTC | Report an error |
Negative as reported in the filing.
Not in this report's XBRL: Revenue, Interest expense.
Values as filed in XBRL (SEC company facts); quarterly values are the filer's 3-month figures, never derived.
IDS
Identifiers
- SEC CIK
- 0001611747
- Ticker
- SCNI
- Record ID
- sx:sec:0001611747
OTHER SITES · YOUR CLICK · THEY SHOW THEIR OWN DATA
Open in
Open in…
Price and chart
News
Analyst estimates and earnings
Institutional holders
Short interest
Official social
Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.
19 FACTS · EACH LINKS TO ITS FILING
Facts
| Fact | Value | As of | Source | Retrieved | Report |
|---|---|---|---|---|---|
| SEC entity type | operating | 2026-11-17 | SEC EDGAR company profile | 2026-11-22 04:58 UTC | Report an error |
| SIC industry | 2836 Biological Products, (No Diagnostic Substances) | 2026-11-17 | SEC EDGAR company profile | 2026-11-22 04:58 UTC | Report an error |
| State of incorporation | L3 | 2026-11-17 | SEC EDGAR company profile | 2026-11-22 04:58 UTC | Report an error |
| Fiscal year end (MMDD) | 1231 | 2026-11-17 | SEC EDGAR company profile | 2026-11-22 04:58 UTC | Report an error |
| Business address | JERUSALEM BIOPARK, 2ND FLOOR, HADASSAH EIN KEREM CAMPUS, JERUSALEM, L3, 00000 | 2026-11-17 | SEC EDGAR company profile | 2026-11-22 04:58 UTC | Report an error |
| Exchanges | Nasdaq | 2026-11-17 | SEC EDGAR company profile | 2026-11-22 04:58 UTC | Report an error |
| Revenue (fiscal year ended 2025-12-31) | $1,311,000 | 2025-12-31 | 20-F, XBRL Revenues | 2026-11-22 04:58 UTC | Report an error |
| Net income (loss) (fiscal year ended 2025-12-31) | $-8,307,000 | 2025-12-31 | 20-F, XBRL NetIncomeLoss | 2026-11-22 04:58 UTC | Report an error |
| Total assets (at 2025-12-31) | $11,626,000 | 2025-12-31 | 20-F, XBRL Assets | 2026-11-22 04:58 UTC | Report an error |
| Stockholders' equity (at 2025-12-31) | $8,103,000 | 2025-12-31 | 20-F, XBRL StockholdersEquity | 2026-11-22 04:58 UTC | Report an error |
| Cash and cash equivalents (at 2025-12-31) | $1,661,000 | 2025-12-31 | 20-F, XBRL CashAndCashEquivalentsAtCarryingValue | 2026-11-22 04:58 UTC | Report an error |
| Operating cash flow (fiscal year ended 2025-12-31) | $-6,031,000 | 2025-12-31 | 20-F, XBRL NetCashProvidedByUsedInOperatingActivities | 2026-11-22 04:58 UTC | Report an error |
| Capital expenditures (property, plant and equipment) (fiscal year ended 2025-12-31) | $24,000 | 2025-12-31 | 20-F, XBRL PaymentsToAcquirePropertyPlantAndEquipment | 2026-11-22 04:58 UTC | Report an error |
| Operating lease liabilities (at 2025-12-31) | $1,961,000 | 2025-12-31 | 20-F, XBRL OperatingLeaseLiability | 2026-11-22 04:58 UTC | Report an error |
| Form D total offering amount (D filed 2024-01-12) | $1,694,259 | 2024-01-12 | D | 2026-11-22 04:58 UTC | Report an error |
| Form D total amount sold (D filed 2024-01-12) | $1,694,259 | 2024-01-12 | D | 2026-11-22 04:58 UTC | Report an error |
| Form D industry group | Pharmaceuticals | 2024-01-12 | D | 2026-11-22 04:58 UTC | Report an error |
| Form D revenue range | No Revenues | 2024-01-12 | D | 2026-11-22 04:58 UTC | Report an error |
| Form D date of first sale | 2023-12-29 | 2024-01-12 | D | 2026-11-22 04:58 UTC | Report an error |
EVERY DATED RECORD, NEWEST FIRST
Timeline
- 2026-11-17 Filing 6-K filed (REPORT OF FOREIGN PRIVATE ISSUER)
- 2026-11-10 Filing 424B3 filed (PROSPECTUS)
- 2026-11-09 Filing EFFECT filed
- 2026-11-09 Filing 6-K filed (REPORT OF FOREIGN PRIVATE ISSUER)
- 2026-10-28 Filing F-3 filed (REGISTRATION STATEMENT)
- 2026-10-20 Filing 6-K filed (REPORT OF FOREIGN PRIVATE ISSUER)
- 2026-10-16 Filing 6-K filed (REPORT OF FOREIGN PRIVATE ISSUER)
- 2026-10-15 Filing 6-K filed (REPORT OF FOREIGN PRIVATE ISSUER)
- 2026-10-13 Filing 6-K filed (REPORT OF FOREIGN PRIVATE ISSUER)
- 2026-10-05 Filing EFFECT filed
- 2026-09-24 Filing F-1 filed (REGISTRATION STATEMENT)
- 2026-09-21 Filing 6-K filed (REPORT OF FOREIGN PRIVATE ISSUER)
- 2026-09-08 Filing 6-K filed (REPORT OF FOREIGN PRIVATE ISSUER)
- 2026-08-28 Filing EFFECT filed
- 2026-08-27 Filing POS AM filed (POST-EFFECTIVE AMENDMENT NO. 1 TO FORM F-1)
- 2026-08-26 Filing 6-K filed (REPORT OF FOREIGN PRIVATE ISSUER)
- 2026-08-19 Filing 6-K filed (REPORT OF FOREIGN PRIVATE ISSUER)
- 2026-06-17 Filing 6-K filed (REPORT OF FOREIGN PRIVATE ISSUER)
- 2026-06-15 Filing 6-K filed (REPORT OF FOREIGN PRIVATE ISSUER)
- 2026-06-08 Filing 6-K filed (REPORT OF FOREIGN PRIVATE ISSUER)
- 2026-05-19 Filing EFFECT filed
- 2026-05-19 Filing 424B3 filed (PROSPECTUS)
- 2026-05-15 Filing CORRESP filed
- 2026-05-14 Filing UPLOAD filed
- 2026-05-12 Filing 6-K filed (REPORT OF FOREIGN PRIVATE ISSUER)
WHAT IS NOT HERE
Gaps
- Court records: not covered yet (expected 11-19).
- No EIN on the SEC filing, so no Form 990 lookup
- SEC 13F holders: no CUSIP stated in a Schedule 13G/13D for this company
- USAspending: no recipient whose SAM legal name and address match this SEC filer
SOURCES AND LICENSE
Sources
- SEC EDGAR: checked · 2026-11-22T04:58:54Z
- Propublica 990: checked, nothing found · 2026-11-22T04:58:54Z
- SEC 13F holdings: checked, nothing found · 2026-11-22T04:58:54Z
- USAspending: checked, nothing found · 2026-11-22T04:58:55Z
CC BY 4.0 -- credit Seraphix Systems.
API
Use this record
Records are free to read and reuse under CC BY 4.0 -- credit Seraphix Systems. The same records as JSON: GET /v1/search?q= and GET /v1/record/<id> (without a key, up to 50 record lookups a day per visitor). No key: single records, pages, feeds and bulk files are free; cross-company search and the live stream cost $0.002 a call via x402. Free key: 100 calls a month, no card. Get a free key or a paid key; send Authorization: Bearer <key>.